Hao-Wei Wang, M.D., Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10, Room 3S235H
- Bethesda, MD 20892
- 301-480-8043
- hao-wei.wang@nih.gov
RESEARCH SUMMARY
Dr. Wang is a hematopathologist focused on refining the diagnosis of hematologic malignancies. He is developing new strategies in multiparametric flow cytometry for detection of minimal residual diseases, characterization of therapeutic targets, and immune monitoring after targeted immunotherapy. He also has expertise in virus-associated lymphoproliferative disorders, including Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease and primary effusion lymphoma. He is developing new tools to improve the diagnosis and stratification of these diseases.
Areas of Expertise
Research
Dr. Wang is a hematopathologist in the Laboratory of Pathology. He has been actively working on the genetic and epigenetic landscapes of T-cell lymphomas. He also has expertise in virus-associated lymphoproliferative disorders, such as Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease and primary effusion lymphoma. He is developing new tools to improve the diagnosis and stratification of these diseases. He is also developing new strategies in multiparametric flow cytometry for detection of minimal residual diseases, characterization of therapeutic targets and monitoring of adoptively transferred immune cells in the era of cancer immunotherapy.
Publications
Biography
Hao-Wei Wang, M.D., Ph.D.
Dr. Wang received his M.D. from the National Taiwan University and his Ph.D. in Cell Biology from the Weill Cornell Medicine of Cornell University. He completed his residency training in anatomic pathology and fellowship in hematopathology at the NCI, and joined the Laboratory of Pathology as a Staff Clinician in 2018.
